| Income Statement | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-09-30 |
|---|---|---|---|---|
| Operating income | 66,267 | 66,298 | 63,367 | 50,909 |
| Other income, net | 4,768 | 2,995 | 7,919 | 6,296 |
| Net income before income taxes | 71,035 | 69,293 | 71,286 | 57,205 |
| Income tax provision | 18,252 | 17,185 | 14,549 | 13,321 |
| Net income | 52,783 | 52,108 | 56,737 | 43,884 |
| Unrealized gain (loss) on available-for-sale securities, net of tax of 9, 0, 19 and 4, respectively | -31 | 48 | -81 | - |
| Comprehensive income | 52,752 | 52,156 | 56,656 | 43,884 |
| Diluted weighted average common shares outstanding | 127,090,194 | 127,543,284 | 126,957,982 | 125,407,279 |
| Earnings per share, basic | 0.43 | 0.43 | 0.47 | 0.37 |
| Earnings per share, diluted | 0.42 | 0.41 | 0.45 | 0.35 |
| Weighted average number of shares outstanding, basic | 122,600,730 | 122,163,212 | 121,472,468 | 118,931,153 |
CATALYST PHARMACEUTICALS, INC. (CPRX)
CATALYST PHARMACEUTICALS, INC. (CPRX)